Abstract:BACKGROUND:Small nucleolar RNA host gene (SNHG) long noncoding RNAs (lncRNAs) are frequently dysregulated in human cancers and involved in tumorigenesis and progression. SNHG17 has been reported as a candidate oncogene in several cancer types, however, its regulatory role in colorectal cancer (CRC) is unclear.METHODS:SNHG17 expression in multiple CRC cohorts was assessed by RT-qPCR or bioinformatic analyses. Cell viability was evaluated using Cell Counting Kit-8 (CCK-8) and colony formation assays. Cell mobility and invasiveness were assessed by Transwell assays. Tumor xenograft and metastasis models were applied to confirm the effects of SNHG17 on CRC tumorigenesis and metastasis in vivo. Immunohistochemistry staining was used to measure protein expression in cancer tissues. RNA pull-down, RNA immunoprecipitation, chromatin immunoprecipitation, and dual luciferase assays were used to investigate the molecular mechanism of SNHG17 in CRC.RESULTS:Using multiple cohorts, we confirmed that SNHG17 is aberrantly upregulated in CRC and correlated with poor survival. In vitro and in vivo functional assays indicated that SNHG17 facilitates CRC proliferation and metastasis. SNHG17 impedes PES1 degradation by inhibiting Trim23-mediated ubiquitination of PES1. SNHG17 upregulates FOSL2 by sponging miR-339-5p, and FOSL2 transcription activates SNHG17 expression, uncovering a SNHG17-miR-339-5p-FOSL2-SNHG17 positive feedback loop.CONCLUSIONS:We identified SNHG17 as an oncogenic lncRNA in CRC and identified abnormal upregulation of SNHG17 as a prognostic risk factor for CRC. Our mechanistic investigations demonstrated, for the first time, that SNHG17 promotes tumor growth and metastasis through two different regulatory mechanisms, SNHG17-Trim23-PES1 axis and SNHG17-miR-339-5p-FOSL2-SNHG17 positive feedback loop, which may be exploited for CRC therapy.

Positive feedback of SuFu negating protein 1 on Hedgehog signaling promotes colorectal tumor growth

Differential regulation of Gli proteins by Sufu in the lung affects PDGF signaling and myofibroblast development.

Hedgehog signaling pathway member SuFu in colorectal cancer

Dual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup Medulloblastoma.

Inhibition of the Transcription Factor ZNF281 by SUFU to Suppress Tumor Cell Migration

Nek2a/Sufu Feedback Loop Regulates Gli-Mediated Hedgehog Signaling Pathway

SRSF10 Facilitates HCC Growth and Metastasis by Suppressing CD8+T Cell Infiltration and Targeting SRSF10 Enhances Anti-Pd-l1 Therapy

Nek2A Phosphorylates and Stabilizes SuFu: A New Strategy of Gli2/Hedgehog Signaling Regulatory Mechanism.

Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review)

SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development

P4HA2 hydroxylates SUFU to regulate the paracrine Hedgehog signaling and promote B-cell lymphoma progression

Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis

SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer.

Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms

POMP Interacts with Suppressor of Fused in Regulating Hedgehog Signaling

SUFU suppresses ferroptosis sensitivity in breast cancer cells via Hippo/YAP pathway

SNHG17 Promotes Colorectal Tumorigenesis and Metastasis Via Regulating Trim23-PES1 Axis and Mir-339-5p-fosl2-snhg17 Positive Feedback Loop

Nuclear Receptor Coactivator SRC-1 Promotes Colorectal Cancer Progression Through Enhancing GLI2-mediated Hedgehog Signaling.

Dual activation of Hedgehog and Wnt/β-catenin signaling pathway caused by downregulation of SUFU targeted by miRNA-150 in human gastric cancer

Members of the Rusc Protein Family Interact with Sufu and Inhibit Vertebrate Hedgehog Signaling.

Interacting Proteins of Tumor Suppressor SuFu by Yeast Two Hybrid